Nutex Health (NASDAQ:NUTX) Stock Price Expected to Rise, Benchmark Analyst Says

Nutex Health (NASDAQ:NUTX) had its price target increased by stock analysts at Benchmark from $45.00 to $60.00 in a report released on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Benchmark’s price objective suggests a potential upside of 114.98% from the stock’s previous close.

Separately, Maxim Group lifted their target price on Nutex Health from $45.00 to $50.00 and gave the stock a “buy” rating in a research report on Tuesday.

Nutex Health Stock Performance

NASDAQ NUTX opened at $27.91 on Tuesday. The company’s fifty day moving average is $22.67 and its two-hundred day moving average is $13.60. Nutex Health has a 52-week low of $4.16 and a 52-week high of $39.90. The company has a debt-to-equity ratio of 3.04, a current ratio of 1.59 and a quick ratio of 1.55. The firm has a market capitalization of $141.39 million, a price-to-earnings ratio of -2.97 and a beta of 0.11.

Insider Buying and Selling

In other Nutex Health news, CFO Jon Christian Bates purchased 1,350 shares of the stock in a transaction on Thursday, August 22nd. The shares were purchased at an average price of $21.46 per share, with a total value of $28,971.00. Following the acquisition, the chief financial officer now directly owns 2,277 shares of the company’s stock, valued at $48,864.42. This represents a 100.00 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 38.52% of the stock is owned by company insiders.

Institutional Investors Weigh In On Nutex Health

Institutional investors have recently added to or reduced their stakes in the stock. Essex Investment Management Co. LLC bought a new position in shares of Nutex Health during the 3rd quarter worth approximately $1,579,000. Thompson Davis & CO. Inc. bought a new position in shares of Nutex Health during the third quarter valued at $494,000. Finally, International Assets Investment Management LLC acquired a new stake in shares of Nutex Health in the 3rd quarter valued at $188,000. 5.32% of the stock is owned by institutional investors and hedge funds.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.